High-flow nasal oxygen (HFNO) is noninferior to noninvasive ventilation (NIV) for endotracheal intubation or death within ...
A scoping review uncovers variability in measuring functional recovery among respiratory failure survivors, highlighting the ...
Discover why high-flow nasal oxygen therapy is a comfortable and effective alternative to traditional noninvasive ventilation ...
The Global Mechanical Ventilator Market has experienced significant growth, expanding from a valuation of $2.94 billion in 2019 to an estimated $12.54 billion by 2027. This report provides an in-depth ...
The latest report from Future Market Insights reveals promising growth for the global mechanical ventilator market, with sales reaching USD 6 billion in 2023. With a projected compound annual growth ...
Compared with noninvasive ventilation, high-flow nasal oxygen met prespecified criteria for noninferiority for the primary ...
France: In non-COPD patients at high risk of extubation failure, prophylactic noninvasive ventilation (NIV) alternating with ...
Compared with noninvasive ventilation, high-flow nasal oxygen met prespecified criteria for noninferiority for the primary outcome of endotracheal intubation or death within 7 days in 4 of the 5 ...